Literature DB >> 8409978

Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve.

T N Jelsma1, H H Friedman, M Berkelaar, G M Bray, A J Aguayo.   

Abstract

The expression of TrkB mRNAs was investigated in rat retina and optic nerve. A 11.5 kb transcript that encodes full-length TRKB was found to predominate in Northern blots of retinal RNA. By in situ hybridization, this trkB expression was concentrated in the ganglion cell and inner nuclear layers. Furthermore, an antibody to the full-length TRKB immunostained retinal ganglion cells and their axons. In contrast, Northern blots of optic nerve RNA showed a prominent 9.5 kb band that encoded a form of the TRKB receptor lacking the tyrosine kinase domain. This species was also detected in both the sciatic nerve and cultured astrocytes and C6 glioma cells. These results suggest that neurons express the full-length TRKB containing the tyrosine kinase domain, while non-neuronal cells express the truncated form of the receptor. These two classes of TRKB may mediate different neurotrophic actions in the retina and optic nerve.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409978     DOI: 10.1002/neu.480240907

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  26 in total

1.  TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo.

Authors:  Li Cheng; Przemyslaw Sapieha; Pavla Kittlerova; William W Hauswirth; Adriana Di Polo
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

2.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

3.  Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells.

Authors:  H Sawai; D B Clarke; P Kittlerova; G M Bray; A J Aguayo
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

4.  Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress.

Authors:  Vivek K Gupta; Yuyi You; Jonathan C Li; Alexander Klistorner; Stuart L Graham
Journal:  J Mol Neurosci       Date:  2012-10-07       Impact factor: 3.444

5.  Brain-derived neurotrophic factor and neurotrophin receptors modulate glutamate-induced phase shifts of the suprachiasmatic nucleus.

Authors:  S Michel; J P Clark; J M Ding; C S Colwell
Journal:  Eur J Neurosci       Date:  2006-08       Impact factor: 3.386

Review 6.  BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death.

Authors:  Y T Ma; T Hsieh; M E Forbes; J E Johnson; D O Frost
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

7.  A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the pro-survival extracellular signal-regulated kinases 1/2 pathway.

Authors:  Mohammadali Almasieh; Christopher J Lieven; Leonard A Levin; Adriana Di Polo
Journal:  J Neurochem       Date:  2011-08-12       Impact factor: 5.372

Review 8.  Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina.

Authors:  A J Weber; C D Harman; S Viswanathan
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

9.  Treatment in vitro of retinal cells with IL-4 increases the survival of retinal ganglion cells: the involvement of BDNF.

Authors:  Leandro de Araujo-Martins; Raphael Monteiro de Oliveira; Gabriela Velozo Gomes dos Santos; Renata Cláudia Celestino dos Santos; Aline Araujo dos Santos; Elizabeth Giestal de Araujo
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

Review 10.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.